These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31587421)

  • 1. Clinical diagnosis of sensory neuropathy in HIV patients treated with tenofovir: A 6-month follow-up study.
    Pillay P; Wadley AL; Cherry CL; Karstaedt AS; Kamerman PR
    J Peripher Nerv Syst; 2019 Dec; 24(4):304-313. PubMed ID: 31587421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
    Ellis RJ; Rosario D; Clifford DB; McArthur JC; Simpson D; Alexander T; Gelman BB; Vaida F; Collier A; Marra CM; Ances B; Atkinson JH; Dworkin RH; Morgello S; Grant I;
    Arch Neurol; 2010 May; 67(5):552-8. PubMed ID: 20457954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
    Wadley AL; Cherry CL; Price P; Kamerman PR
    J Pain Symptom Manage; 2011 Apr; 41(4):700-6. PubMed ID: 21145196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
    Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
    J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.
    Jamieson L; Evans D; Brennan AT; Moyo F; Spencer D; Mahomed K; Maskew M; Long L; Rosen S; Fox MP
    HIV Med; 2017 Sep; 18(8):595-603. PubMed ID: 28332270
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Gaff J; Octaviana F; Pillay P; Mbenda HGN; Ariyanto IA; Gan JA; Cherry CL; Kamerman P; Laws SM; Price P
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral neuropathy in HIV: prevalence and risk factors.
    Evans SR; Ellis RJ; Chen H; Yeh TM; Lee AJ; Schifitto G; Wu K; Bosch RJ; McArthur JC; Simpson DM; Clifford DB
    AIDS; 2011 Apr; 25(7):919-28. PubMed ID: 21330902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
    Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
    Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
    Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
    AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
    Maritz J; Benatar M; Dave JA; Harrison TB; Badri M; Levitt NS; Heckmann JM
    Muscle Nerve; 2010 May; 41(5):599-606. PubMed ID: 20229576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy.
    Mehta SA; Ahmed A; Laverty M; Holzman RS; Valentine F; Sivapalasingam S
    Clin Infect Dis; 2011 Sep; 53(5):490-6. PubMed ID: 21844033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in CAMKK2 associate with susceptibility to sensory neuropathy in HIV patients treated without stavudine.
    Gaff J; Octaviana F; Ariyanto I; Cherry C; Laws SM; Price P
    J Neurovirol; 2019 Dec; 25(6):814-824. PubMed ID: 31309408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.
    Pahuja M; Grobler A; Glesby MJ; Karim F; Parker G; Gumede S; Naidoo K
    Antivir Ther; 2012; 17(4):737-43. PubMed ID: 22414588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV neuropathy in pre-HAART patients and it's correlation with risk factors in Central India.
    Dubey TN; Raghuvanshi SS; Sharma H; Saxena R
    Neurol India; 2013; 61(5):478-80. PubMed ID: 24262448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.
    Shikuma CM; Bennett K; Ananworanich J; Gerschenson M; Teeratakulpisarn N; Jadwattanakul T; DeGruttola V; McArthur JC; Ebenezer G; Chomchey N; Praihirunkit P; Hongchookiat P; Mathajittiphun P; Nakamoto B; Hauer P; Phanuphak P; Phanuphak N;
    J Neurovirol; 2015 Oct; 21(5):525-34. PubMed ID: 26002840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy.
    Moketla MB; Wadley AL; Kamerman P; de Assis Rosa D
    PLoS One; 2018; 13(10):e0204111. PubMed ID: 30273369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CAMKK2 polymorphisms in HIV-associated sensory neuropathy in South Africans.
    Gaff J; Pillay P; Cherry C; Laws SM; Price P; Kamerman P
    J Neurol Sci; 2020 Sep; 416():116987. PubMed ID: 32585444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir.
    Vos AG; Chersich MF; Klipstein-Grobusch K; Zuithoff P; Moorhouse MA; Lalla-Edward ST; Kambugu A; Kumarasamy N; Grobbee DE; Barth RE; Venter WD
    Retrovirology; 2018 Dec; 15(1):77. PubMed ID: 30547820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa.
    Peters RP; Van Ramshorst MS; Struthers HE; McIntyre JA
    Eur J Pediatr; 2014 Sep; 173(9):1245-8. PubMed ID: 24691679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.